Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Peptide, GnRH analog.
Non-selective HDAC inhibitor.
Alkaline phosphatase substrate used to quantify...
Peptide found in molluscs, cardiomodulator.
Terpene found in the rind of various citrus fru...
GHB agonist, D2/3 antagonist.
BHA derivative.
Synthesis intermediate
Benzyl taxol analog; potential microtubule depo...
Insecticide; α-adrenergic agonist, MAO inhibit...
Epoxide metabolite of acrylamide, induces DNA a...
Alkaloid compound originally found in Corydalis...
α2-adrenergic agonist.
Hydroxycinnamic aicd, verbascoside metabolite, ...
JAK2 inhibitor, potential EGFR inhibitor.
β1-adrenergic antagonist.
Non-nitrogen bisphosphonate; mitochondrial ATP/...
Used for in vitro fertilization; FIASMA, SERM.<...
ALK inhibitor.
Synthetic nitrile compound